ReviewJournal of nanobiotechnology2025
Enzymatic functionalization of bacterial nanocellulose: current approaches and future prospects.
Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Cellulose-Based Interfacial Solar Steam Generation: Material Classification, Architectural Design, and Multifunctional Strategies.Polymers · 2026Review
- Peculiarities of Bacterial Cellulose.Polymers · 2026Review
- Sustainable Cellulose Enables Blue Energy Toward Osmotic Energy Conversion.Nano-micro letters · 2026Review
- Transforming Cellulose for Sustainability: Comprehensive Insights into Modification Approaches and Their Applications.ACS omega · 2026Review
- Bacterial Nanocellulose Functionalization for Smart Bioelectronics: Integration into Biosensing, Neural Interfaces, and Tissue Engineering.ACS polymers Au · 2025Review
- Microbial Valorization of Agricultural and Agro-Industrial Waste into Bacterial Cellulose: Innovations for Circular Bioeconomy Integration.Microorganisms · 2025Review
- Transcriptional reprogramming of Novacetimonas hansenii SI1 during growth on glycerol.Applied microbiology and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Faced with the challenges of modern industry and medicine associated with the dynamic development of civilization, there is a constantly growing demand for the production of novel functional materials that are clearly oriented towards fulfilling specific applications. Herein, we provide an overview of the current status and recent findings related to the enzymatic functionalization of bacterial nanocellulose. Commonly, biocellulose modification involves the utilization of simple and cost-effective chemical and/or physical approaches. However, these methods may have an adverse effect on both the biological properties of the biomaterial and the natural environment. An alternative to these procedures is the highly specific enzymatic modification of bacterial nanocellulose, which perfectly fits into the assumptions of green technologies, making the process eco-friendly and not limiting any outlooks for further usage of the obtained biocomposites. The employment of enzymes for the targeted alteration of this material's properties is based on either a direct method, such as controlled hydrolysis and nanofication [i.e., synthesis of different morphological forms of bacterial cellulose (e.g., rod-shaped nanocrystals)] using cellulases, and/or attachment of reactive functional groups into the polymer structure via oxidation (e.g., utilizing a laccase/TEMPO catalytic system or lytic polysaccharide monooxygenases) and esterification catalyzed by lipases; or an indirect procedure involving the application of bacterial nanocellulose as a matrix for enzyme immobilization (e.g., laccase, glucose oxidase, horseradish peroxidase, lysozyme, bromelain, lipase, papain), thus creating a specific catalytic system. Overall, enzymatic functionalization of bacterial nanocellulose is a sustainable and promising strategy to create biocomposites with tailored properties for a wide range of industrial and medical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.